OUR PRODUCTS

MOBILE APPS

GENERAL INFO

LGND

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Ligand Pharmaceuticals (LGND) Earnings Date & Reports

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

LGND is expected to report earnings to rise 15.00% to $1.84 per share on November 05

Ligand Pharmaceuticals LGND Stock Earnings Reports

Q3'25

Est.

$1.84

Q2'25

Beat

by $0.17

Q1'25

Beat

by $0.11

Q4'24

Beat

by $0.09

Q3'24

Beat

by $0.50

The last earnings report on August 07 showed earnings per share of $1.60, beating the estimate of $1.43. With 9.40K shares outstanding, the current market capitalization sits at 3.10B.

View a ticker or compare two or three

Compare

LGND

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For LGND
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LGND showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a biotechnology company

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

555 Heritage Drive

Phone

+1 858 550-7500

Employees

Web

https://www.ligand.com